Industry Perspectives on the WHO Essential Diagnostics List

The use of essential drugs. Model list of essential drugs (seventh list). Fifth report of the WHO Expert Committee.

No wonder you activities are, reading will be always needed. It is not only to fulfil the duties that you need to finish in deadline time. Reading will encourage your mind and thoughts. Of course, reading will greatly develop your experiences about everything. Reading the use of essential drugs model list of essential drugs seventh list fifth report of the who expert committee world health orga...

A comparative analysis of the Libyan national essential medicines list and the WHO model list of essential medicines

AIM AND OBJECTIVES To examine the concordance of the Libyan Pharmaceutical List of Essential Medicines (LPLEM) with the World Health Organization Model List of Essential Medicines 2009 (WMLEM 2009). METHODS The concordance between generic medicines listed in the WMLEM 2009 (standard reference list) and the LPLEM 2006 (comparator list) was evaluated. RESULTS The total number of Basic Essenti...

WHO to launch first essential medicines list for children.

Perspectives on Molecular Diagnostics Automation

LA Oc After a lively discussion at LabAutomation2005 in San Jose, we asked three major diagnostic companies to share their vision for the molecular diagnostics ‘‘rapidgrowing-and-more-than-ever’’ market. Happily, all of them complied and we are pleased to present insight from Bayer Healthcare, Beckman Coulter, and Roche Molecular Systems. To complement these perspectives, we invited a heavy use...

Perspectives on the pharmaceutical industry.

This paper seeks to provide an economic perspective on the pharmaceutical industry, which has come under increasing criticism on a number of issues. In the main, that criticism amounts to a rather ineffective flailing at the supply side of the market for pharmaceutical products-much of it based on inaccurate perceptions-when a more productive policy would be to strengthen the hitherto weak and ...